NEO1 and brain neoplasm: The hypothesis that hepcidin value changes in brain tumors has emerged in comparison with the corresponding normal tissues, according to variation of other parameters such as, HFE, neogenin (NEO1), receptor 1 for transferrin (TFR) and receptor 2 for transferrin (TFR2) [24,32].